Rhumbline Advisers Hookipa Pharma Inc. Transaction History

Rhumbline Advisers

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.33 - $2.31 $18,776 - $32,612	-14,118 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.26 - $2.52 $783 - $1,567	-622 Reduced 4.22%	14,118 $32,000
Q4 2021 Feb 10, 2022	SELL	$2.33 - $5.94 $233 - $594	-100 Reduced 0.67%	14,740 $34,000
Q3 2021 Nov 12, 2021	BUY	$5.89 - $9.35 $8,540 - $13,557	1,450 Added 10.83%	14,840 $87,000
Q2 2021 Aug 05, 2021	BUY	$9.16 - $19.51 $122,652 - $261,238	13,390 New	13,390 $123,000
Q3 2020 Nov 12, 2020	SELL	$8.59 - $11.89 $93,888 - $129,957	-10,930 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.23 - $12.1 $79,023 - $132,253	10,930 New	10,930 $127,000

23.7M

98.5K

46.6K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $219M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.